Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06283355 · ClinicalTrials.gov registry record · Phase 1
Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome
A Phase 1 study of Microbial Colonization and Staphylococcus Aureus, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 175
- Enrollment target
- 1
- Study location
NCT06283355 is a Phase 1 study of Microbial Colonization and Staphylococcus Aureus that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 175 participants, below the 12,646-participant average among 20 other Microbial Colonization trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06283355, a Phase 1 study of Microbial Colonization and Staphylococcus Aureus, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 175 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to determine whether a parent-to-child nasal microbiota transplant (NMT) can seed and engraft parental organisms into the neonatal microbiome and increase the neonatal microbiome diversity.
Conditions Studied
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL Nasal Microbiota Transplant (NMT)
Study Locations (1)
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2024-09-03 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06283355
The ClinicalTrials.gov registry entry for NCT06283355 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,646-participant average among 20 other Microbial Colonization trials with a reported enrollment target (99% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Microbial Colonization appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06283355 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT06283355 about?
NCT06283355 is a clinical study titled "Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome". This study aims to determine whether a parent-to-child nasal microbiota transplant (NMT) can seed and engraft parental organisms into the neonatal microbiome and increase the neonatal microbiome diversity.
What is the current status of trial NCT06283355?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 175 participants. The study started on 2024-09-03. Estimated completion is 2026-12-31.
What conditions does trial NCT06283355 study?
This clinical trial studies the following conditions: Microbial Colonization, Staphylococcus Aureus, Neonatal Infection.
What interventions are being tested in trial NCT06283355?
The interventions under investigation include: Placebo (BIOLOGICAL), Nasal Microbiota Transplant (NMT) (BIOLOGICAL).
Who is sponsoring clinical trial NCT06283355?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06283355 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Microbial Colonization
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment
RECRUITING · Phase 1
-
Microbiome Derived Metabolism and Pharmacokinetics
RECRUITING · Phase 1
-
Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant
ACTIVE NOT RECRUITING · Phase 1
-
Changes in Microbial Status From Dentate, Edentulous and After Dental Implant Placement
RECRUITING
-
Skin Preparation for Elective Foot and Ankle Surgery
RECRUITING · Phase 4
-
Effects of Mouthrinse on the Microbiome of the Oral Cavity and GI Tract
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.